Charterhouse buys Novetude Santé

The deal values the company at around €100m, Unquote understands.

The GP bought its stake from BIM, the holding company controlled by Novetude's founder, Robert Zolade.

Following the deal, the management team will retain a minority stake in the business.

Charterhouse intends to boost the company's growth, bolster its international expansion and pursue a buy-and-build strategy.

The GP is currently investing its Charterhouse Capital Partners X fund, which held a  €2.3bn final close in 2016 and is largely deployed. The firm has recently registered a new buyout fund, which has a target of around €2.5bn.

Company
Headquartered in Paris, Novetude Santé provides higher education to healthcare professionals. It manages 17 schools with 6,000 students across France, specialising in osteopathy education.

The company also offers healthcare training, professional development courses for nurses, dentist assistants and pharmacists, and preparatory classes for university medical exams.

Novetude Santé generates annual revenues of around €37m, Unquote understands.

People
Charterhouse – Lionel Giacomotto (managing partner).
Novetude Santé – Robert Zolade (founder).

Advisers
Equity – EY-Parthenon (commercial due diligence); Eight Advisory (financial due diligence); Mayer Brown (tax); HPML (legal).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• France
• Consumer
• Charterhouse Capital Partners
• France